![](/img/cover-not-exists.png)
31PTargeted therapy for patients with ALK positive NSCLC: Results from the transalpine cohort
Britschgi, C., Rechsteiner, M., Delaloye, R., Früh, M., Metro, G., Gautschi, O., Rothschild, S.I., Stahel, R.A., Wild, P.J., Curioni-Fontecedro, A.Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx089.002
Date:
April, 2017
File:
PDF, 59 KB
english, 2017